✦ LIBER ✦

Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications

✍ Scribed by Yiannakopoulou, E Ch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomics of Human Drug Transport

✍ Ishikawa, Toshihisa; Kim, Richard B.; König, Jörg 📂 Article 📅 2013 🏛 John Wiley & Sons, Inc. ⚖ 197 KB

Pharmacogenomics of drug-metabolizing en

✍ Sim, S. C. (author);Kacevska, M. (author);Ingelman-Sundberg, M. (author) 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 629 KB

Pharmacogenomics of drug-metabolizing en

✍ Sim, S. C. (author);Kacevska, M. (author);Ingelman-Sundberg, M. (author) 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 629 KB

Drug Discovery and Evaluation: Safety an

✍ Vogel, H. Gerhard; Maas, Jochen; Hock, Franz J.; Mayer, Dieter 📂 Article 📅 2013 🏛 Springer Berlin Heidelberg ⚖ 328 KB

REGULATION OF DRUG-METABOLIZING ENZYMES

✍ Aitken, Alison E.; Richardson, Terrilyn A.; Morgan, Edward T. 📂 Article 📅 2006 🏛 Annual Reviews 🌐 English ⚖ 282 KB

Clinical implications of pharmacogenetic

✍ Julia Kirchheiner; Angela Seeringer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 480 KB